發(fā)布時間：2019-01-01 11:40

【摘要】：目的探討改良曼氏手術治療重度盆腔器官脫垂伴宮頸延長的療效及對患者生活質量的影響。方法選擇2012年1月至2013年4月Ⅲ~Ⅳ期盆腔器官脫垂92例患者,其中50例伴宮頸延長患者行改良曼氏手術作為改良曼氏組,42例行植入網(wǎng)片的盆底重建術作為植入網(wǎng)片組。比較兩組患者的手術時間、術中出血量、尿管保留時間、術后住院時間、總住院時間及總住院費用;術后1、6、12個月進行隨訪,填寫盆底功能障礙問卷簡表20(PFDI-20)、盆底功能影響問卷簡表7(PFIQ-7)及盆底器官脫垂/尿失禁性生活影響問卷(PISQ-12),評估手術對患者生活質量和性生活質量的影響。結果改良曼氏組與植入網(wǎng)片組的手術時間[(86.3±19.0)min,(83.7±20.3)min]、出血量[(82.9±80.6)ml,(67.0±52.1)ml]比較,差異無統(tǒng)計學意義(P0.05)。兩組保留尿管時間[(4.4±1.6)d,(3.5±1.1)d)]、術后恢復時間[(7.7±2.2)d,(6.3±1.6)d]、總住院時間[(12.5±2.4)d,(9.7±2.7)d]、住院費用[(22 919.5±6 413.3)元,(6 513.5±2 329.3)元]比較,差異均有統(tǒng)計學意義(P均0.01)。植入網(wǎng)片組術前和術后12個月PFDI-20評分分別為(80.6±57.9)分和(30.2±73.8)分;PFIQ-7分別為(84.4±45.5)分和(27.8±33.4)分;改良曼氏組術前和術后12個月PFDI-20評分分別為(74.0±66.0)分和(10.0±23.0)分;PFIQ-7評分分別為(68.5±45.8)分和(18.3±30.3)分,兩組術前、術后比較,差異均無統(tǒng)計學意義(P0.05)。植入網(wǎng)片組尿潴留2例,網(wǎng)片暴露1例;改良曼氏組尿潴留1例,兩組患者均無復發(fā)。結論改良曼氏手術是治療伴宮頸延長重度POP有效、安全、微創(chuàng)的手術之一,可以明顯改善患者的生命質量,與植入網(wǎng)片盆底重建術療效相當。
[Abstract]:Objective to investigate the effect of modified Mann's operation on severe pelvic organ prolapse with cervical extension and its effect on quality of life (QOL). Methods from January 2012 to April 2013, 92 patients with pelvic organ prolapse were selected. Among them, 50 patients with cervical extension underwent modified Mann's operation and 42 patients underwent pelvic floor reconstruction with mesh implantation. The operation time, intraoperative bleeding volume, retention time of urinary catheter, postoperative hospitalization time, total hospitalization time and total hospitalization cost were compared between the two groups. The patients were followed up at 1: 6 and 12 months after operation. The pelvic floor dysfunction questionnaire (PFDI-20), pelvic floor function impact questionnaire (PFIQ-7) and pelvic floor prolapse / urinary incontinence (PISQ-12) were completed. To evaluate the effect of surgery on patients' quality of life and sexual life. Results there was no significant difference in operative time (86.3 鹵19.0) min, (, 83.7 鹵20.3 min) and blood loss (82.9 鹵80.6) ml, (, 67.0 鹵52.1) ml) between the modified Mann group and the mesh implantation group (P0.05). The duration of retention of urinary catheter [(4.4 鹵1.6) d, () 3.5 鹵1.1) d)], postoperative recovery time [(7.7 鹵2.2) d, (6.3 鹵1.6) days], total hospitalization time [(12.5 鹵2.4) days] in both groups. The cost of hospitalization [(22 919.5 鹵6 413.3) yuan, (6 513.5 鹵2 329.3) yuan] was significantly different (P < 0. 01). The PFDI-20 scores were (80.6 鹵57.9) and (30.2 鹵73.8), the PFIQ-7 scores were (84.4 鹵45.5) and (27.8 鹵33.4) in the mesh implantation group. The PFDI-20 scores before and 12 months after operation were (74.0 鹵66.0) and (10.0 鹵23.0) in modified Mann's group. The PFIQ-7 scores were (68.5 鹵45.8) and (18.3 鹵30.3), respectively. There was no significant difference between the two groups before and after operation (P0.05). There were 2 cases of urinary retention and 1 case of net exposure in the implanted mesh group, and 1 case in the modified Mann group. No recurrence was found in both groups. Conclusion modified Mann's operation is one of the effective, safe and minimally invasive procedures for the treatment of severe POP with cervical extension. It can significantly improve the quality of life of the patients and is comparable to the effect of pelvic floor reconstruction.
【作者單位】： 首都醫(yī)科大學附屬北京婦產(chǎn)醫(yī)院;
【基金】：北京市科學技術委員會首都市民健康項目培育(Z111107067311024)
【分類號】：R713

【相似文獻】

相關期刊論文 前10條

1 李永春;曼氏手術治療子宮Ⅲ度脫垂11例分析[J];現(xiàn)代診斷與治療;2000年S1期

2 黃東云;;曼氏手術治療子宮脫垂在基層醫(yī)院的應用[J];廣西醫(yī)學;2007年11期

3 肖雅麗;江輝;謝靈芝;;曼氏手術配合盆底重建治療年輕子宮脫垂5例臨床分析[J];中國醫(yī)藥指南;2011年18期

4 李雅萍;;曼氏手術治療子宮脫垂10例[J];基層醫(yī)學論壇;2008年23期

5 譚敏華;;曼氏手術治療子宮脫垂56例臨床分析[J];亞太傳統(tǒng)醫(yī)藥;2012年08期

6 郭蓮芬;手術治療676例子宮脫垂的分析[J];北京醫(yī)學;1980年02期

7 楊于恒;;手術治療子宮脫垂(附78例分析)[J];青海醫(yī)藥雜志;1985年02期

8 孫月艷;不同手術方式治療子宮脫垂的療效研究[J];浙江創(chuàng)傷外科;2005年05期

9 劉玲;王運根;;手術治療老年婦女子宮脫垂臨床探討[J];中國現(xiàn)代醫(yī)學雜志;2011年14期

10 宋萌穎,馬秋芹;子宮脫垂術后復發(fā)5例原因分析[J];青海醫(yī)藥雜志;2004年11期

，

本文編號：2397507